role of parp inhibition and i/o therapy in tnbc
Published 4 years ago • 85 plays • Length 6:08Download video MP4
Download video MP3
Similar videos
-
6:10
role of parp inhibition and i/o therapy in tnbc
-
7:23
combining parp and checkpoint inhibitors in tnbc
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
1:13
addressing the role of parp inhibitors in different breast cancer settings
-
1:24
dr. burris on the potential of parp inhibitors in tnbc
-
4:59
future role of parp inhibition in brca breast cancer
-
5:53
combining parp inhibitors checkpoint inhibitors in tnbc
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
21:21
role of immunotherapy and parp inhibitors
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
5:06
ovarian cancer: the role of parp inhibitors and beyond
-
20:42
role of immunotherapy and parp inhibitors
-
5:09
potential role for parp inhibitor and pd-l1 inhibitor in metastatic triple negative breast cancer
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
7:42
parp inhibitors in other subtypes of breast cancer
-
8:04
chemotherapy and parp inhibitors in bc
-
17:53
role of immunotherapy and parp inhibitors